CN100475228C - 一种杏香兔耳风提取物及其制备方法 - Google Patents
一种杏香兔耳风提取物及其制备方法 Download PDFInfo
- Publication number
- CN100475228C CN100475228C CNB2005100753844A CN200510075384A CN100475228C CN 100475228 C CN100475228 C CN 100475228C CN B2005100753844 A CNB2005100753844 A CN B2005100753844A CN 200510075384 A CN200510075384 A CN 200510075384A CN 100475228 C CN100475228 C CN 100475228C
- Authority
- CN
- China
- Prior art keywords
- fragrans champ
- extract
- ainsliasa fragrans
- gained
- ainsliasa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 22
- 241001038618 Ainsliaea fragrans Species 0.000 title abstract description 11
- 238000000605 extraction Methods 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000003814 drug Substances 0.000 claims description 19
- 239000011347 resin Substances 0.000 claims description 16
- 229920005989 resin Polymers 0.000 claims description 16
- 238000009835 boiling Methods 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 9
- 229930003944 flavone Natural products 0.000 claims description 8
- 235000011949 flavones Nutrition 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000002242 deionisation method Methods 0.000 claims description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 150000002212 flavone derivatives Chemical class 0.000 claims description 4
- 150000002213 flavones Chemical class 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- -1 lactone compound Chemical class 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 7
- 239000000470 constituent Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000003988 chronic cervicitis Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100753844A CN100475228C (zh) | 2005-06-16 | 2005-06-16 | 一种杏香兔耳风提取物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100753844A CN100475228C (zh) | 2005-06-16 | 2005-06-16 | 一种杏香兔耳风提取物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1709417A CN1709417A (zh) | 2005-12-21 |
CN100475228C true CN100475228C (zh) | 2009-04-08 |
Family
ID=35705748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100753844A Expired - Fee Related CN100475228C (zh) | 2005-06-16 | 2005-06-16 | 一种杏香兔耳风提取物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100475228C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101318946B (zh) * | 2008-04-10 | 2010-11-10 | 中国人民解放军第二军医大学 | 化合物二聚兔耳风萜a及其制备方法和应用 |
CN101332216B (zh) * | 2008-05-20 | 2012-06-06 | 北京星昊医药股份有限公司 | 杏香兔耳风总酚酸提取物及其制备方法 |
CN101293003B (zh) * | 2008-06-17 | 2011-10-26 | 江西佑美制药有限公司 | 一种杏香兔耳风有效部位及其制备方法和应用 |
CN101664427B (zh) * | 2009-09-15 | 2011-08-10 | 江西天施康中药股份有限公司 | 一种含杏香兔耳风提取物中药制剂的制备方法 |
CN108014157A (zh) * | 2017-12-31 | 2018-05-11 | 长沙湘资生物科技有限公司 | 杏香兔耳风提取物在抗菌消炎药物中的应用 |
CN115040476B (zh) * | 2022-06-24 | 2023-04-21 | 武昌理工学院 | 一种复方血三七降糖口服液及其制备方法和应用 |
-
2005
- 2005-06-16 CN CNB2005100753844A patent/CN100475228C/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
兔耳风属植物研究概况. 张锐等.江西中医药学院学报,第17卷第2期. 2005 |
兔耳风属植物研究概况. 张锐等.江西中医药学院学报,第17卷第2期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1709417A (zh) | 2005-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101035548B (zh) | 甾体皂苷药物组合物及其制备方法和应用 | |
CN101396384B (zh) | 一种积雪草提取物及其制备方法 | |
CN102138966B (zh) | 藏茵陈提取物及其制备方法、药物组合物和用途 | |
CN100475228C (zh) | 一种杏香兔耳风提取物及其制备方法 | |
CN101647828B (zh) | 一种用离子交换树脂分离中药总生物碱的方法 | |
CN102746362A (zh) | 从黄芪中提取精制黄芪甲苷的方法 | |
CN101172991B (zh) | 一种从木豆枝叶中提取纯化牡荆苷和异牡荆苷的方法 | |
CN101361812A (zh) | 一种大黄甘草制剂的制备方法 | |
CN100415255C (zh) | 一种中药组合物及其制备方法 | |
CN102078443A (zh) | 一种药物组合物及其用途和制剂 | |
CN109232491A (zh) | 一种华泽兰中苯并呋喃类化合物的制备方法及用途 | |
CN101371882A (zh) | 一种茵陈蒿汤制剂的制备方法 | |
Wu et al. | Preparation of paeoniflorin from the stems and leaves of Paeonia lactiflora Pall.‘Zhongjiang’through green efficient microwave-assisted extraction and subcritical water extraction | |
CN100502880C (zh) | 一种三七二醇皂苷组合物及其制备方法和用途 | |
CN104971088A (zh) | 藏茵陈提取物及其制备方法、药物组合物和用途 | |
CN101531721B (zh) | 一种三萜皂苷单体的工业化制备方法 | |
CN102172361A (zh) | 一种用离子交换树脂分离中药总生物碱的方法 | |
CN100371340C (zh) | 胡黄连苷ii单体的制备方法及其治疗乙型肝炎的药物剂型 | |
CN102670935B (zh) | 一种从藠头中提取总皂苷的方法 | |
CN101642492B (zh) | 治疗慢性盆腔炎的药物及其制备方法 | |
CN112250655B (zh) | 两种新的环状二苯基庚烷类化合物及其制备方法和用途 | |
CN100584345C (zh) | 具抗病毒作用的小紫金牛提取物及其提取方法和应用 | |
CN1068782C (zh) | 以栾树提取物为有效组分的抗癌药物及制备方法 | |
CN102188497B (zh) | 延胡索总碱的制备方法及延胡索制剂及其应用 | |
CN101322734A (zh) | 具有抗炎免疫作用的轮叶党参总皂苷及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ZHONGCHUANG PHARMACEUTICAL TECHNOLOGY CO Free format text: FORMER OWNER: JIANGXI HUIREN PHARMACEUTICAL CO., LTD. Effective date: 20070330 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070330 Address after: 201203 Zhangjiang hi tech park, Li Shizhen Road, No. 396, third, fourth floor, Shanghai Applicant after: SHANGHAI ZHONGCHUANG PHARMACEUTICAL TECHNOLOGY CO.,LTD. Address before: 330043 1189 Yingbin Avenue, Nanchang, Jiangxi Applicant before: Jiangxi Huiren Pharmaceutical Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160105 Address after: 201203, Li Shizhen road 396, Zhangjiang hi tech park, Shanghai Patentee after: Shanghai Kin Kun Pharmaceutical Co.,Ltd. Address before: 201203 Zhangjiang hi tech park, Li Shizhen Road, No. 396, third, fourth floor, Shanghai Patentee before: SHANGHAI ZHONGCHUANG PHARMACEUTICAL TECHNOLOGY CO.,LTD. |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 201203 No. 396 Li Shizhen Road, Shanghai, China (Shanghai) free trade test area Patentee after: Shanghai Kin Kun Pharmaceutical Co.,Ltd. Address before: 201203, Li Shizhen road 396, Zhangjiang hi tech park, Shanghai Patentee before: Shanghai Kin Kun Pharmaceutical Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090408 |
|
CF01 | Termination of patent right due to non-payment of annual fee |